The Official Website of the Acid Maltase Deficiency Association

It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard

Letter From IPA and Genzyme Concerning LOTS

Posted on: June 07, 2006

Dear IPA members, Pompe patients, family members and GSD-net participants,

The IPA board received several questions concerning participation in the LOTS trial.

As there are certain restrictions to the market approval of Myozyme we asked Genzyme to make a written statement. Genzyme kindly provided us with such a statement which you will find attached to this letter.

We hope this will bring some clarity for everyone concerned and answers the questions raised by patients and their family members.

With warm regards,

Ria Broekgaarden

Download the complete letter on from this page.

Disclaimer: The AMDA does not endorse any of the products, medications, treatments or information reported herein. The website and its contents is intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.

Address: AMDA PO Box 700248
San Antonio, Texas 78270 USA